Page last updated: 2024-08-25

zoledronic acid and Minimal Disease, Residual

zoledronic acid has been researched along with Minimal Disease, Residual in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouvet, M; Hayashi, K; Hiroshima, Y; Hoffman, RM; Kimura, H; Matsumoto, Y; Miwa, S; Sugimoto, N; Tsuchiya, H; Uehara, F; Yamamoto, M; Yamamoto, N; Yano, S; Zhang, Y1
Dalla-Pozza, L; Little, D; Munns, C; Padhye, B1
Blohmer, JU; Burchardi, N; Costa, SD; Denkert, C; Dubsky, P; Fasching, PA; Gerber, B; Hanusch, C; Hilfrich, J; Huober, J; Jackisch, C; Kümmel, S; Loibl, S; Mehta, K; Paepke, S; Rezai, M; Schneeweiss, A; Tesch, H; Untch, M; von Minckwitz, G; Zahm, DM1
Bell, R; Burkinshaw, R; Cameron, D; Coleman, RE; Dodwell, D; Gil, M; Keane, MM; Marshall, SJ; Passos-Coelho, JL; Ritchie, D; Thorpe, H; Wheatley, D; Winter, MC1

Trials

3 trial(s) available for zoledronic acid and Minimal Disease, Residual

ArticleYear
Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
    Cancer medicine, 2016, Volume: 5, Issue:5

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Imidazoles; Incidence; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Zoledronic Acid

2016
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 64

    Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Disease-Free Survival; Female; Humans; Imidazoles; Middle Aged; Neoplasm, Residual; Zoledronic Acid

2016
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer.
    British journal of cancer, 2010, Mar-30, Volume: 102, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm, Residual; Zoledronic Acid

2010

Other Studies

1 other study(ies) available for zoledronic acid and Minimal Disease, Residual

ArticleYear
Fluorescence-guided surgery of prostate cancer bone metastasis.
    The Journal of surgical research, 2014, Volume: 192, Issue:1

    Topics: Adenocarcinoma; Animals; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Disease-Free Survival; Green Fluorescent Proteins; Humans; Imidazoles; Luminescent Proteins; Lymphatic Metastasis; Male; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm, Residual; Optical Imaging; Prostatic Neoplasms; Red Fluorescent Protein; Zoledronic Acid

2014